Sign in
4

Changes in Ownership

Moleculin Biotech, Inc. Filed Acc 0001437749-22-015660

Options or other derivatives

  • Director acquired 38,333 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
CANNON MICHAEL D Director 2022-06-20 Grant or award · Stock option (right to buy) +23,333 50,001 D
CANNON MICHAEL D Director 2022-06-20 Grant or award · Stock option (right to buy) +15,000 65,001 D
Loading xslF345X03/rdgdoc.xml…